DK136157C - - Google Patents

Info

Publication number
DK136157C
DK136157C DK328673A DK328673A DK136157C DK 136157 C DK136157 C DK 136157C DK 328673 A DK328673 A DK 328673A DK 328673 A DK328673 A DK 328673A DK 136157 C DK136157 C DK 136157C
Authority
DK
Denmark
Application number
DK328673A
Other languages
Danish (da)
Other versions
DK136157B (da
Inventor
G H Phillipps
C E Newall
Original Assignee
Glaxo Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Laboratories Ltd filed Critical Glaxo Laboratories Ltd
Publication of DK136157B publication Critical patent/DK136157B/da
Application granted granted Critical
Publication of DK136157C publication Critical patent/DK136157C/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J41/00Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
DK328673AA 1972-06-15 1973-06-14 Analogifremgangsmåde til fremstilling af 3alfa-hydroxy-17beta-karboxylsyrederivater af androstanrækken eller salte deraf. DK136157B (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB2811872A GB1434919A (en) 1972-06-15 1972-06-15 3alpha-hydroxy androstanes

Publications (2)

Publication Number Publication Date
DK136157B DK136157B (da) 1977-08-22
DK136157C true DK136157C (fr) 1978-01-23

Family

ID=10270562

Family Applications (1)

Application Number Title Priority Date Filing Date
DK328673AA DK136157B (da) 1972-06-15 1973-06-14 Analogifremgangsmåde til fremstilling af 3alfa-hydroxy-17beta-karboxylsyrederivater af androstanrækken eller salte deraf.

Country Status (9)

Country Link
BE (1) BE800899R (fr)
CA (1) CA1040619A (fr)
DE (1) DE2330342A1 (fr)
DK (1) DK136157B (fr)
FR (1) FR2189034B2 (fr)
GB (1) GB1434919A (fr)
LU (1) LU67790A1 (fr)
NL (1) NL7308267A (fr)
ZA (1) ZA734037B (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014169831A1 (fr) 2013-04-17 2014-10-23 Sage Therapeutics, Inc. 19-nor-hétéroaryl-stéroïdes c21-c-liés c3,3-disubstitués et procédés d'utilisation de ceux-ci
HRP20190232T1 (hr) 2013-04-17 2019-03-22 Sage Therapeutics, Inc. 19-nor c3,3-disupstituirani c21-n-pirazolil steroidi i postupci za njihovu upotrebu
ES2807264T3 (es) 2013-04-17 2021-02-22 Sage Therapeutics Inc Esteroides neuroactivos 19-nor para métodos de tratamiento
WO2014169836A1 (fr) 2013-04-17 2014-10-23 Sage Therapeutics, Inc. 19-nor-stéroïdes neuroactifs et procédés d'utilisation de ceux-ci
EP3868382A1 (fr) 2013-07-19 2021-08-25 Sage Therapeutics, Inc. Stéroïdes neuroactifs, compositions et leurs utilisations
SI3488852T1 (sl) 2013-08-23 2021-07-30 Sage Therapeutics, Inc. Nevroaktivni steroidi, sestavki in uporabe le-teh
US10246482B2 (en) 2014-06-18 2019-04-02 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
PT3206493T (pt) 2014-10-16 2020-08-03 Sage Therapeutics Inc Composições e métodos para tratamento de transtornos do snc
SG11201703073UA (en) 2014-10-16 2017-05-30 Sage Therapeutics Inc Compositions and methods for treating cns disorders
US10774108B2 (en) 2014-11-27 2020-09-15 Sage Therapeutics, Inc. Compositions and methods for treating CNS disorders
ES2857082T3 (es) 2015-01-26 2021-09-28 Sage Therapeutics Inc Composiciones y métodos para el tratamiento de trastornos del SNC
JP6875996B2 (ja) 2015-02-20 2021-05-26 セージ セラピューティクス, インコーポレイテッド 神経刺激性ステロイド、組成物、およびその使用
EP3481844B1 (fr) 2016-07-11 2024-04-17 Sage Therapeutics, Inc. Stéroïdes neuroactifs substitués en c12 et méthodes d'utilisation associées
IL264129B2 (en) 2016-07-11 2024-05-01 Sage Therapeutics Inc C17, c20, and c21 substituted neuroactive steroids and their methods of use
AR119047A1 (es) 2019-05-31 2021-11-17 Sage Therapeutics Inc Esteroides neuroactivos como moduladores de gabaa y su uso en el tratamiento de trastornos del snc

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH273860A (de) * 1942-04-25 1951-02-28 Nv Organon Verfahren zur Herstellung einer im Ring C eine sauerstoffhaltige Gruppe enthaltenden Verbindung der Cyclopentanopolyhydrophenanthren-Reihe.
BE776786A (fr) * 1970-12-17 1972-06-16 Glaxo Lab Ltd Composes de la serie du pregnane et de l'androstane a activite anesthesique
GB1380246A (en) * 1970-12-17 1975-01-08 Glaxo Lab Ltd 3alpha-hydroxy-androstanes and esters thereof

Also Published As

Publication number Publication date
GB1434919A (en) 1976-05-12
FR2189034A2 (fr) 1974-01-25
BE800899R (fr) 1973-12-14
AU5693773A (en) 1974-12-19
ZA734037B (en) 1974-05-29
CA1040619A (fr) 1978-10-17
DK136157B (da) 1977-08-22
NL7308267A (fr) 1973-12-18
DE2330342A1 (de) 1974-01-17
LU67790A1 (fr) 1973-08-16
FR2189034B2 (fr) 1977-01-21

Similar Documents

Publication Publication Date Title
JPS5215791Y2 (fr)
JPS5146966Y2 (fr)
JPS4997572U (fr)
CS151393B1 (fr)
CS152941B1 (fr)
CS153168B1 (fr)
CH576733A5 (fr)
CH579846A5 (fr)
BG18373A1 (fr)
BG19426A1 (fr)
BG19534A1 (fr)
BG20735A1 (fr)
BG21391A3 (fr)
BG22963A1 (fr)
CH561448A5 (fr)
CH562665A5 (fr)
CH563460A5 (fr)
CH566052B5 (fr)
CH569310A5 (fr)
CH569327A5 (fr)
CH572213A5 (fr)
CH573056A5 (fr)
CH574146A5 (fr)
CH574565A5 (fr)
CH570503A5 (fr)